IRIDEX Overview

  • Founded
  • 1989

Founded
  • Status
  • Public

  • Employees
  • 170

Employees
  • Stock Symbol
  • IRIX

Stock Symbol
  • Investments
  • 3

  • Share Price
  • $3.37

  • (As of Friday Closing)

IRIDEX General Information

Description

IRIDEX Corp is involved in the business of developing, manufacturing and marketing laser-based medical systems, delivery devices and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, service and support activities. The geographical segments of the company include the United States, Europe, the Americas, excluding the U.S and Asia/Pacific Rim.

Contact Information

Website
www.iridex.com
Formerly Known As
IRIS Medical Instruments
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Other Devices and Supplies
Other Industries
Surgical Devices
Stock Exchange
NAS
Primary Office
  • 1212 Terra Bella Avenue
  • Mountain View, CA 94043
  • United States
+1 (650) 000-0000

IRIDEX Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IRIDEX Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.37 $3.41 $2.45 - $9.46 $54.2M 15.9M 36.4K -$0.35

IRIDEX Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 52,341 74,264 27,451 21,324
Revenue 55,331 53,903 36,347 43,447
EBITDA (4,772) (4,382) (5,799) (8,077)
Net Income (5,606) (5,225) (6,329) (8,813)
Total Assets 48,024 48,687 27,969 34,813
Total Debt 2,417 2,656 4,188 3,209
Public Fundamental Data provided by Morningstar, Inc. disclaimer

IRIDEX Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore IRIDEX‘s full profile, request access.

Request a free trial

IRIDEX Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
IRIDEX Corp is involved in the business of developing, manufacturing and marketing laser-based medical systems, delivery
Other Devices and Supplies
Mountain View, CA
170 As of 2022
000.00
000000000 - 000.00

00000

t aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse ci
00000000000 0000000
Lake Forest, CA
000 As of 0000
00000000

000000

it esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
00000000 0000000
Kalamazoo, MI
00000 As of 0000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

IRIDEX Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Staar Surgical Corporate Backed or Acquired Lake Forest, CA 000 00000000
0000000 Formerly VC-backed Kalamazoo, MI 00000 00000000
0000 0000000 Formerly PE-Backed Clearwater, FL 000 0000 00000000 0000
0000000 Formerly VC-backed San Clemente, CA 000 00000 00000000000 00000
00000 0000000 0000 Corporation Mawson Lakes, Australia 000 000.00 000000000 000.00
You’re viewing 5 of 17 competitors. Get the full list »

IRIDEX Patents

IRIDEX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200206521-A1 Electrical methods and devices for ophthalmic treatment Pending 27-Dec-2018 00000000000
US-20200069463-A1 Methods and systems for large spot retinal laser treatment Pending 31-Aug-2018 000000000
EP-3843642-A1 Methods and systems for large spot retinal laser treatment Pending 31-Aug-2018 000000000
US-11351059-B2 Probes having fiber taper and fluid collection channel for ophthalmic laser treatment Active 17-Aug-2018 000000000
US-20200054488-A1 Probes having fiber taper and fluid collection channel for ophthalmic laser treatment Granted 17-Aug-2018 A61F9/00781
To view IRIDEX’s complete patent history, request access »

IRIDEX Executive Team (6)

Name Title Board Seat Contact Info
Fuad Ahmad Interim Chief Financial Officer
Patrick Mercer Chief Operating Officer, Operations
David Bruce Chief Executive Officer & Board Member
You’re viewing 3 of 6 executive team members. Get the full list »

IRIDEX Board Members (10)

Name Representing Role Since
Beverly Huss Self Board Member 000 0000
David Bruce Self Chief Executive Officer & Board Member 000 0000
Kenneth Ludlum IRIDEX Board Member 000 0000
Maria Sainz IRIDEX Board Member 000 0000
Nandini Devi IRIDEX Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

IRIDEX Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IRIDEX Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 (00000 10-Mar-2021 000000000 Buildings and Property 00000 000
000000 000000 10-Mar-2021 0000000000 00.000 Diagnostic Equipment 00000 000
RetinaLabs (Ophthalmology Line) 08-Apr-2010 Merger/Acquisition 00.00 Other Commercial Products 00000000
To view IRIDEX’s complete investments and acquisitions history, request access »